help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gomez-Sanchez, C. E.
Right arrow Articles by Holland, O. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gomez-Sanchez, C. E.
Right arrow Articles by Holland, O. B.

Journal of Clinical Endocrinology & Metabolism, Vol 52, 214-219, Copyright © 1981 by Endocrine Society


ARTICLES

Urinary tetrahydroaldosterone and aldosterone-18-glucuronide excretion in white and black normal subjects and hypertensive patients

CE Gomez-Sanchez and OB Holland

Urinary aldosterone excretion is commonly determined by assay of aldosterone liberated from the acid-labile metabolite, aldosterone-18- glucuronide (Aldo-18-G), which reflects 5-15% of aldosterone secretion. However, since 3alpha, 5beta-tetrahydroaldosterone (TH-Aldo), the major metabolite, reflects 15-40% of aldosterone excretion, determination of its excretion should usually provide a more accurate index of aldosterone secretion. We have validated a RIA for urinary TH-Aldo and compared its excretion in black and white normal subjects and patients with essential hypertension and primary aldosteronism during consumption of low, normal, and high sodium diets. Urinary TH-Aldo excretion averaged 4.5 +/- 2.0 (mean +/- SD) times that of Aldo-18-G. The ratio of excretion of the two remained relatively constant during low, normal, and high sodium diets. There was no difference in the excretion of TH-Aldo or Aldo-18-G in black vs. white normal subjects or hypertensive patients and no age-related changes in the excretion of either metabolite from 20-60 yr of age. Two of nine patients with primary aldosteronism had normal Also-18-G excretion but elevated TH- Aldo excretion. We conclude that determination of both metabolites increases the diagnostic accuracy for primary aldosteronism.


This article has been cited by other articles:


Home page
Eur J EndocrinolHome page
C. Schirpenbach, L. Seiler, C. Maser-Gluth, F. Rudiger, C. Nickel, F. Beuschlein, and M. Reincke
Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites.
Eur. J. Endocrinol., June 1, 2006; 154(6): 865 - 873.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
C. Girard, O. Barbier, G. Veilleux, M. El-Alfy, and A. Belanger
Human Uridine Diphosphate-Glucuronosyltransferase UGT2B7 Conjugates Mineralocorticoid and Glucocorticoid Metabolites
Endocrinology, June 1, 2003; 144(6): 2659 - 2668.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. H. Pratt, W. T. Ambrosius, R. Agarwal, G. J. Eckert, and S. Newman
Racial Difference in the Activity of the Amiloride-Sensitive Epithelial Sodium Channel
Hypertension, December 1, 2002; 40(6): 903 - 908.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. E Gomez-Sanchez
Primary aldosteronism and its variants
Cardiovasc Res, January 1, 1998; 37(1): 8 - 13.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1981 by The Endocrine Society